Biopeak

Biopeak is an advanced wellness and longevity startup pioneering personalized, preventive healthcare in India. The company leverages a unique blend of multiomics diagnostics, high-resolution imaging and artificial intelligence to predict health risks and deliver tailored interventions. Biopeak’s approach is rooted in “Medicine 4.0”—a model that emphasizes proactive, predictive, and personalized care, moving beyond conventional reactive healthcare. Biopeak’s core market is India, with a focus on urban, health-conscious individuals, high-performing professionals, athletes and those with chronic or unresolved health issues.

Core Products and Services

• Multiomics Diagnostics: Comprehensive lab tests, organic acid profiling, gut microbiome mapping, salivary cortisol rhythms, and whole-exome functional genomics.

• Advanced Imaging: High-resolution MRI, CT, DXA, ECHO, and carotid IMT to detect early-stage physiological changes.

• Non-Invasive Tissue Screening: Intracellular mineral levels, toxin load, glycation, and oxidative stress assessment for metabolic and cellular health.

• Personalized Healthspan Programs: Tailored plans for women’s health, gut and skin longevity, metabolic optimization, and cognitive support.

• AI-Driven Health Insights: Predictive analytics to map disease trajectories and enable early intervention.

• Concierge-Style Care: Dedicated health managers and multidisciplinary teams guide clients through phased, evolving health plans with regular follow-ups.

• Remote and In-Clinic Access: Many diagnostics and consultations are available remotely, with in-person visits for advanced testing and therapies.

Key milestones

• 2024: Founded and incorporated in Bengaluru, Karnataka.

• March 2025: Launched its first longevity clinic in Bengaluru.

• June 2025: Raised $3.5 million in seed funding led by Accel’s Prashanth Prakash, NKSquared (Zerodha’s Nikhil Kamath), and Ranjan Pai’s Claypond Capital, with the round potentially closing at $5 million.

• 2025: Established partnerships with IISc and Longevity India to tailor interventions for South Asian genetics and lifestyles.

Business Model & Revenue Streams

• Clinic-Based Service Fees: Revenue from in-person diagnostics, consultations, and ongoing care at Biopeak’s longevity clinics (primary revenue stream).

• Personalized Program Subscriptions: Recurring revenue from digital healthspan programs, remote consultations and follow-up testing.

• Specialized Modules: Additional fees for targeted women’s health, performance optimization and advanced imaging packages.

• Institutional Partnerships: Collaborative research and data-driven projects with academic and healthcare institutions.

Customer Segmentation

• B2C (core): Health-conscious individuals, high performers and those with chronic or complex health concerns.

• B2B/B2I (emerging): Partnerships with research institutions and wellness-focused organizations.

Top Clients & Partnerships

Key Partners:

• Indian Institute of Science (IISc): Research and contextualization of healthspan protocols for South Asian populations.
• Longevity India: Scientific forum for aging biology, with Accel’s Prashanth Prakash as a founding patron.

Investor-Partners:

• Accel (Prashanth Prakash), NKSquared (Nikhil Kamath), Claypond Capital (Ranjan Pai), and Rainmatter (Zerodha).

Future Outlook & Strategic Priorities

• Clinic Expansion: Rapid rollout of longevity clinics across major Indian cities within the next year.

• AI and Platform Development: Deepening scientific research and scaling the AI-driven diagnostics platform for greater personalization and predictive accuracy.

• New Program Launches: Specialized modules for women’s health, metabolic optimization and cognitive longevity.

• Institutional Collaborations: Strengthening partnerships with leading research and healthcare institutions to contextualize protocols for Indian genetics and environments.